238 related articles for article (PubMed ID: 29142140)
1. Imaging and CSF analyses effectively distinguish CJD from its mimics.
Rudge P; Hyare H; Green A; Collinge J; Mead S
J Neurol Neurosurg Psychiatry; 2018 May; 89(5):461-466. PubMed ID: 29142140
[TBL] [Abstract][Full Text] [Related]
2. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels.
Lattanzio F; Abu-Rumeileh S; Franceschini A; Kai H; Amore G; Poggiolini I; Rossi M; Baiardi S; McGuire L; Ladogana A; Pocchiari M; Green A; Capellari S; Parchi P
Acta Neuropathol; 2017 Apr; 133(4):559-578. PubMed ID: 28205010
[TBL] [Abstract][Full Text] [Related]
3. The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review.
Chohan G; Pennington C; Mackenzie JM; Andrews M; Everington D; Will RG; Knight RS; Green AJ
J Neurol Neurosurg Psychiatry; 2010 Nov; 81(11):1243-8. PubMed ID: 20855493
[TBL] [Abstract][Full Text] [Related]
4. High Diagnostic Accuracy of RT-QuIC Assay in a Prospective Study of Patients with Suspected sCJD.
Fiorini M; Iselle G; Perra D; Bongianni M; Capaldi S; Sacchetto L; Ferrari S; Mombello A; Vascellari S; Testi S; Monaco S; Zanusso G
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019068
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of surrogate CSF biomarkers for Creutzfeldt-Jakob disease in the era of RT-QuIC.
Abu-Rumeileh S; Baiardi S; Polischi B; Mammana A; Franceschini A; Green A; Capellari S; Parchi P
J Neurol; 2019 Dec; 266(12):3136-3143. PubMed ID: 31541342
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients.
Baldeiras IE; Ribeiro MH; Pacheco P; Machado A; Santana I; Cunha L; Oliveira CR
J Neurol; 2009 Sep; 256(9):1540-50. PubMed ID: 19418113
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the impact of CSF prion RT-QuIC and amended criteria on the clinical diagnosis of Creutzfeldt-Jakob disease: a 10-year study in Italy.
Mastrangelo A; Mammana A; Baiardi S; Tiple D; Colaizzo E; Rossi M; Vaianella L; Polischi B; Equestre M; Poleggi A; Capellari S; Ladogana A; Parchi P
J Neurol Neurosurg Psychiatry; 2023 Feb; 94(2):121-129. PubMed ID: 36428087
[TBL] [Abstract][Full Text] [Related]
8. Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease.
Llorens F; Zafar S; Ansoleaga B; Shafiq M; Blanco R; Carmona M; Grau-Rivera O; Nos C; Gelpí E; Del Río JA; Zerr I; Ferrer I
Neuropathol Appl Neurobiol; 2015 Aug; 41(5):631-45. PubMed ID: 25134744
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study.
Coulthart MB; Jansen GH; Olsen E; Godal DL; Connolly T; Choi BC; Wang Z; Cashman NR
BMC Neurol; 2011 Oct; 11():133. PubMed ID: 22032272
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Clinical Features, Diagnostic Tests, and Biomarkers in Patients With Suspected Creutzfeldt-Jakob Disease, 2014-2021.
Shir D; Lazar EB; Graff-Radford J; Aksamit AJ; Cutsforth-Gregory JK; Jones DT; Botha H; Ramanan VK; Prusinski C; Porter A; Day GS
JAMA Netw Open; 2022 Aug; 5(8):e2225098. PubMed ID: 35921110
[TBL] [Abstract][Full Text] [Related]
11. Total and Phosphorylated Cerebrospinal Fluid Tau in the Differential Diagnosis of Sporadic Creutzfeldt-Jakob Disease and Rapidly Progressive Alzheimer's Disease.
Hermann P; Haller P; Goebel S; Bunck T; Schmidt C; Wiltfang J; Zerr I
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215868
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review.
Koscova S; Zakova Slivarichova D; Tomeckova I; Melicherova K; Stelzer M; Janakova A; Kosorinova D; Belay G; Mitrova E
Mol Neurobiol; 2017 Oct; 54(8):5919-5927. PubMed ID: 27665282
[TBL] [Abstract][Full Text] [Related]
13. Clinical and laboratory features of 14 young Chinese probable sCJD patients.
Shi Q; Xiao K; Chen C; Zhou W; Gao C; Wang J; Zhang BY; Wang Y; Dong XP
Prion; 2017 Mar; 11(2):128-135. PubMed ID: 28278113
[TBL] [Abstract][Full Text] [Related]
14. Comparison Between Sporadic and Misdiagnosed Sporadic Creutzfeldt-Jakob Disease: A Report of Two Cases.
Zhao X; Yu Y; Zhao Z; Xu J
Cell Biochem Biophys; 2015 Jun; 72(2):311-5. PubMed ID: 25556070
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias.
Vitali P; Maccagnano E; Caverzasi E; Henry RG; Haman A; Torres-Chae C; Johnson DY; Miller BL; Geschwind MD
Neurology; 2011 May; 76(20):1711-9. PubMed ID: 21471469
[TBL] [Abstract][Full Text] [Related]
16. CSF Tau proteins reduce misdiagnosis of sporadic Creutzfeldt-Jakob disease suspected cases with inconclusive 14-3-3 result.
Leitão MJ; Baldeiras I; Almeida MR; Ribeiro MH; Santos AC; Ribeiro M; Tomás J; Rocha S; Santana I; Oliveira CR
J Neurol; 2016 Sep; 263(9):1847-61. PubMed ID: 27357003
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Accuracy of Prion Disease Biomarkers in Iatrogenic Creutzfeldt-Jakob Disease.
Llorens F; Villar-Piqué A; Hermann P; Schmitz M; Calero O; Stehmann C; Sarros S; Moda F; Ferrer I; Poleggi A; Pocchiari M; Catania M; Klotz S; O'Regan C; Brett F; Heffernan J; Ladogana A; Collins SJ; Calero M; Kovacs GG; Zerr I
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32059611
[TBL] [Abstract][Full Text] [Related]
18. Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease.
Dorey A; Tholance Y; Vighetto A; Perret-Liaudet A; Lachman I; Krolak-Salmon P; Wagner U; Struyfs H; De Deyn PP; El-Moualij B; Zorzi W; Meyronet D; Streichenberger N; Engelborghs S; Kovacs GG; Quadrio I
JAMA Neurol; 2015 Mar; 72(3):267-75. PubMed ID: 25559883
[TBL] [Abstract][Full Text] [Related]
19. Concordance of cerebrospinal fluid real-time quaking-induced conversion across the European Creutzfeldt-Jakob Disease Surveillance Network.
McKenzie N; Piconi G; Culeux A; Hammarin AL; Stergiou C; Tzartos S; Versleijen AAM; van de Geer J; Cras P; Cardone F; Ladogana A; Mannana A; Rossi M; Bongianni M; Perra D; Regelsberger G; Klotz S; Hornemann S; Aguzzi A; Schmitz M; Andrews M; Burns K; Haïk S; Ruiz-García R; Verner-Carlsson J; Tzartos J; Verbeek MM; De Vil B; Poleggi A; Parchi P; Zanusso G; Gelpi E; Frontzek K; Reimann R; Hermann P; Zerr I; Pal S; Green A
Eur J Neurol; 2022 Aug; 29(8):2431-2438. PubMed ID: 35524506
[TBL] [Abstract][Full Text] [Related]
20. High sensitivity of an ELISA kit for detection of the gamma-isoform of 14-3-3 proteins: usefulness in laboratory diagnosis of human prion disease.
Matsui Y; Satoh K; Miyazaki T; Shirabe S; Atarashi R; Mutsukura K; Satoh A; Kataoka Y; Nishida N
BMC Neurol; 2011 Oct; 11():120. PubMed ID: 21970675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
